Skip to content
All Sources
All Years


Tribute to Dr. Stephen Harrison (1969-2024)

The liver community mourns the loss of Dr. Stephen Harrison, a visionary in MASLD clinics and clinical research, whose contributions have shaped the current state of the field. Dr. Stephen Harrison was…


EASL Statement on Resmetirom FDA approval

After over 20 years of dedicated research and drug development, the FDA has granted approval for the first anti-MASH drug. This marks a pivotal moment for patients battling MASH, whose quality of…

Back To Top